Vimarsana
Biggest News Aggregation in the World

Page 16 - Air Force Material Command News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Air Force Material Command. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Air Force Material Command Today - Breaking & Trending Today

CytoSorbents Reports First Quarter 2022 Results and Revises 2022 Outlook - Vimarsana News

CytoSorbents Reports First Quarter 2022 Results and Revises 2022 Outlook

Q1 2022 total revenue was $8.7 million, including product sales of $7.9 million.  Core non-COVID-19 product sales were an estimated $7.6 million, ...

CytoSorbents Reports First Quarter 2022 Results and Revises 2022 Outlook - Vimarsana News

CytoSorbents Reports First Quarter 2022 Results and Revises 2022 Outlook

/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

CytoSorbents Reports First Quarter 2022 Results and Revises 2022 Outlook - Vimarsana News

CytoSorbents Reports First Quarter 2022 Results and Revises 2022 Outlook

/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

CytoSorbents Awarded Preferred Supplier Agreement with Asklepios, One of the Largest Private Hospital Operators in Germany - Vimarsana News

CytoSorbents Awarded Preferred Supplier Agreement with Asklepios, One of the Largest Private Hospital Operators in Germany

MONMOUTH JUNCTION, N.J., May 2, 2022 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening condit...

First Patient Enrolled in U.S. STAR-D Pivotal Trial Evaluating the DrugSorb™-ATR Antithrombotic Removal System to Remove Apixaban and Rivaroxaban During Cardiothoracic Surgery - Vimarsana News

First Patient Enrolled in U.S. STAR-D Pivotal Trial Evaluating the DrugSorb™-ATR Antithrombotic Removal System to Remove Apixaban and Rivaroxaban During Cardiothoracic Surgery

/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using...